$PCVX
Vaxcyte, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · San Carlos, CA
PCVX chart
What traders are saying about $PCVX
Latest postsVaxcyte, Inc. news
- Vaxcyte at guggenheim healthcare conference: strong vaccine data, long road By Investing.com
Investing.com UK ·
- 3 Growth Stocks To Watch With Up To 58% Earnings Growth
Yahoo Finance ·
- 3 High Growth Stocks With At Least 33% Earnings Growth
Yahoo Finance ·
- 3 Growth Stocks With Earnings Growth Over 32%
Simply Wall St ·
- Vaxcyte, Inc. (US92243G1085.SG) Seasonal Returns Chart - Yahoo Finance
Yahoo! Finance Canada ·
- Vaxcyte, Inc. (PCVX) Seasonal Returns Chart - Yahoo Finance
Yahoo! Finance Canada ·
- T. Rowe Price updates its reported Vaxcyte (PCVX) stake; one fund holds 5.2%.
Stock Titan ·
- T. Rowe Price updates its reported Vaxcyte (PCVX) stake, with sole voting power over 13.7M shares.
Stock Titan ·
- Vaxcyte Stock Gets A Lift From Strong Vaccine Trial Results
Simply Wall St ·
- Vaxcyte Posts $1.99 Q3 GAAP Loss Per Share, 15 Cents Better Than Estimate
www.tokenpost.com ·
- BofA Securities Maintains Vaxcyte(PCVX.US) With Buy Rating
Moomoo ·
- Form 4 Vaxcyte Inc: Elvia Cowan (SVP, Finance & CAO) For: 2 November
Investing.com Nigeria ·
Vaxcyte, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$766,628 | -$463,927 | -$402,266 | -$223,485 |
| Diluted EPS | $-5.63 | $-3.80 | $-4.14 | $-3.44 |
| Total assets (year end) | $3.00B | $3.51B | $1.41B | $1.01B |
| Cash and equivalents (year end) | $174.0M | $387.9M | $397.5M | $834.7M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Vaxcyte, Inc.
- Ticker
- PCVX (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- San Carlos, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1649094
- Former names
- SutroVax, Inc.
Frequently asked questions
What exchange is Vaxcyte, Inc. listed on?
Vaxcyte, Inc. trades on the Nasdaq under the ticker symbol PCVX.
What industry is Vaxcyte, Inc. in?
Vaxcyte, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Vaxcyte, Inc. headquartered?
Vaxcyte, Inc.'s business address on file with the SEC is in San Carlos, CA.
When does Vaxcyte, Inc.'s fiscal year end?
Vaxcyte, Inc.'s fiscal year ends on December 31.